Australia markets close in 2 hours 6 minutes

Tiziana Life Sciences Ltd (0RP.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.5500-0.0250 (-4.35%)
At close: 11:04AM CET
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Cost of revenue
0
0
0
0
Gross profit
0
0
0
0
Operating expenses
Research development
15,079
13,208
6,360
3,815
Selling general and administrative
855
855
-
-
Total operating expenses
14,896
27,374
32,273
10,193
Operating income or loss
-14,896
-27,374
-32,273
-10,193
Interest expense
151
176
339.3434
95.7151
Total other income/expenses net
-
893
-
-
Income before tax
-14,154
-26,657
-30,073
-10,287
Income tax expense
-3,240
-3,240
-2,343
-708.0296
Income from continuing operations
-10,914
-23,417
-27,731
-9,579
Net income
-10,914
-23,417
-27,731
-9,579
Net income available to common shareholders
-10,914
-23,417
-27,731
-9,579
Basic EPS
-
-0.24
-0.16
-0.03
Diluted EPS
-
-0.24
-0.16
-0.03
Basic average shares
-
97,932
169,065
341,207
Diluted average shares
-
97,932
169,065
341,207
EBITDA
-
-26,340
-29,637
-9,932